E and Z α-C-galactosylceramides by Julia-Lythgoe-Kocienski chemistry: A test of the receptor-binding model for glycolipid immunostimulants

ChemBioChem

Volumn 7, Issue 7, 2006, Pages 1017-1022

  Chen, Guangwu ^a   Chien, May ^c   Tsuji, Moriya ^b,c   Franck, Richard W ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cytokines; E,Z isomers; Galactosylceramide; Glycosides; Julia Lythgoe Kocienski method

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; GLYCOLIPID; GLYCOSIDE; IMMUNOSTIMULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; FEMALE; GALACTOSYLCERAMIDES; GLYCOSIDES; ISOMERISM; MICE; MICE, INBRED C57BL;

EID: 33745884104     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.200500386     Document Type: Article

References (50)

1. a) T. Natori, M. Monta, K. Akimoto, Y. Koezuka, Tetrahedron 1994, 50, 2771-2784.
2. b) Similar materials have been isolated from Agelas clathrodes by the Mangoni group: V. Costantino, E. Fattorusso, C. Imperatore, A. Mangoni, J. Org. Chem. 2004, 69, 1174-1179, and references therein.
3. a) Y. Hayakawa, D. I. Godfrey, M. J. Smyth, Curr. Med. Chem. 2004, 11, 241-252;
4. b) L. Van Kaer, Nat. Rev. Immunol. 2005, 5, 31-42.
5. M. Brigl, M. B. Brenner, Annu. Rev. Immunol. 2004, 23, 817-890.
6. C. R. Berkers, H. Ovaa, Trends Pharmacol. Sci. 2005, 26, 252-257.
7. a) Y. Kinjo, D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C.-H. Wong, M. Kronenberg, Nature 2005, 434, 520-525;
8. b) D. Wu, G. W. Xing, M. A. Poles, A. Horowitz, Y. Kinjo, B. Sullivan, V. Bodmer-Narkevitch, O. Plettenburg, M. Kronenberg, M. Tsuji, D. D. Ho, C.-H. Wong, Proc. Natl. Acad. Sci. USA 2005, 102, 1351-1356;
9. c) J. Mattner, K. L. Debord, N. Ismail, R. D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, K. Hoebe, O. Schneewind, D. Walker, B. Beutler, L. Teyton, P. B. Savage, A. Bendelac, Nature 2005, 434, 525-529.
10. G. W. Xing, D. Wu, M. A. Poles, A. Horowitz, M. Tsuji, D. D. Ho, C.-H. Wong, Bioorg. Med. Chem. 2005, 13, 2907-2916.
11. a) G.-T. Fan, Y.-s. Pan, K.-C. Lu, Y.-P. Cheng, W.-C. Lin, S. Lin, C.-H. Lin, C.-H. Wong, J.-M. Fang, C.-C. Lin, Tetrahedron 2005, 61, 1855-1862;
12. b) K. O. Yu, J. S. Im, A. Molano, Y. Dutronc, P. A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, Y. T. Chang, G. S. Besra, S. A. Porcelli, Proc. Natl. Acad. Sci. USA 2005, 102, 3383-3388;
13. c) F. K. Wallner, L. Chen, A. Moliner, M. Jondal, M. Elofsson, ChemBioChem 2004, 5, 437-444.
14. a) S. Oki, A. Chiba, T. Yamamura, S. Miyake, J. Clin. Invest. 2004, 113, 1631-1640;
15. b) R. D. Goff, Y. Gao, J. Mattner, D. Zhou, N. Yin, C. Cantu III, L. Teyton, A. Bendelac, P. B. Savage, J. Am. Chem. Soc. 2004, 126, 13602-14603;
16. c) K. Murata, T. Toba, K. Nakanishi, B. Takahashi, T. Yamamura, S. Miyake, H. Annoura, J. Org. Chem. 2005, 70, 2398-2401.
17. a) D. M. Zajonc, C. Cantu III, J. Mattner, D. Zhou, P. B. Savage, A. Bendelac, I. A. Wilson, L. Teyton, Nat. Immunol. 2005, 6, 810-818;
18. b) M. Koch, V. S. Strange, D. Shepherd, S. D. Gadola, B. Mathew, G. Ritter, A. R. Fersht, G. S. Besra, R. R. Schmidt , E. Y. Jones, V. Cerundolo, Nat. Immunol. 2005, 6, 819-826.
19. J. Schmieg, G. Yang, R. W. Franck, M. Tsuji, J. Exp. Med. 2003, 198, 1631-1641. In the interests of full disclosure, we did not predict that the C-glycoside would cause a useful change in the ratio of cytokines; our original motivation was conventional, to enhance the stability and life-time of the drug.
20. G. Yang, J. Schmieg, M. Tsuji, R. W. Franck, Angew. Chem. 2004, 116, 3906-3910;
21. Angew. Chem. Int. Ed. 2004, 43, 3818-3822.
22. G. Chen, J. Schmieg, M. Tsuji, R. W. Franck, Org. Lett. 2004, 6, 4077-4080.
23. a) J. B. Baudin, G. Hareau, S. A. Julia, O. Ruel, Tetrahedron Lett. 1991, 32, 1175-1178;
24. b) R. Bellingham, K. Jarowicki, P. Kocienski, V. Martin, Synthesis 1996, 285-296.
25. a) A. Fürstner, M. Albert, J. Mlynarski, M. Matheu, E. DeClercq, J. Am. Chem. Soc. 2003, 125, 13 132-13 142;
26. b) D. R. Williams, A. A. Kiryanov, U. Emde, M. P. Clark, M. A. Berliner, J. T. Reeves, Angew. Chem. 2003, 115, 1296-1300;
27. Angew. Chem. Int. Ed. 2003, 42, 1258-1262;
28. c) R. M. Williams, B. K. Albrecht, Org. Lett. 2003, 5, 197-200;
29. d) N. Cramer, S. Laschat, A. Baro, H. Schwalbe, C. Richter, Angew. Chem. 2005, 117, 831-833;
30. Angew. Chem. Int. Ed. 2005, 44, 820-822;
31. e) C. Jasper, R. Wittenberg, M. Quitschalle, J. Jakupovic, A. Kirschning, Org. Lett. 2005, 7, 479-482;
32. f) P. Liu, E. N. Jacobsen, J. Am. Chem. Soc 2001, 123, 10772-10773;
33. g) A. B. Smith III, Z. Wan, J. Org. Chem. 2000, 65, 3738-3753;
34. h) P. R. Blakemore, J. Chem. Soc. Perkin Trans. 1 2002, 2563-2585, and references therein.
35. 2-sulfone were rejected because of the known epimerizability of α-amino aldehydes, A. Dondoni, N. Catozzi, A. Marra, J. Org. Chem. 2004, 69, 5023-5036.
36. 2 sulfones, "Modern Synthetic Methodologies Toward Glycomimetics" P. S. Belica, A. Berthold, N. Charles, G. Chen, A. Parhi, P. Pasetto, J. Pu, G. Yang, R. W. Franck, ACS Symp. Series 2005, 896, 107-119.
37. W. R. Kobertz, C. R. Bertozzi, M. D. Bednarski, Tetrahedron Lett. 1992, 33, 737-740.
38. a) A. Giannis, K. Sandhoff, Tetrahedron Lett. 1985, 26, 1479-1482;
39. b) M. D. Lewis, J. K. Cha, Y. Kishi, J. Am. Chem. Soc. 1982, 104, 4976-4978.
40. a) G. Brooks, P. D. Edwards, J. D. I. Hatto, T. C. Smale, R. Southgate, Tetrahedron 1995, 51, 7999-8014;
41. b) C. S. Wilcox, G. W. Long, H. Suh, Tetrahedron Lett. 1984, 25, 395-398.
42. P. R. Blakemore, W. J. Cole, P. J. Kocienski, A. Morley, Synlett 1998, 26-28.
43. A. B. Charette, C. Berthelette, D. St-Martin, Tetrahedron Lett. 2001, 42, 5149-5153.
44. D. D. Xu, L. Waykole, J. V. Calienni, L. Ciszewski, G. T. Lee, W. Liu, J. Szewczyk, K. Vargas, K. Prasad, O. Repič, T. J. Blacklock, Org. Process Res. Dev. 2003, 7, 856-865.
45. K. Pekari, R. R. Schmidt, J. Org. Chem. 2003, 68, 1295-1308.
46. a) J. Schmieg G. Yang, R. W. Franck, N. Van Rooijen, M. Tsuji, Proc. Natl. Acad. Sci. USA 2005, 102, 1127-1132;
47. b) S. Fujii, K. Liu, C. Smith, A. J. Bonito, R. M. Steinman. J. Exp. Med. 2004, 199, 1607-1618;
48. c) H. Kitamura, K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, M. Taniguchi, T. Nishimura. J. Exp. Med. 1999, 189, 1121-1128;
49. d) Y.-F. Yang, M. Tomura, S. Ono, T. Hamaoka, H. Fujiwara, Int. Immunol. 2000, 12, 1669-1675.
50. S. K. Dougan, A. Salas, P. Rava, A. Agyemang, A. Kaser, J. Morrison , A. Khurana, M. Kronenberg, C. Johnson, M. Exley, M. M. Hussain, R. S. Blumberg, J. Exp. Med. 2005, 202, 529-539. We thank one of the referees for suggesting this alternative explanation.